Clinical Trial Update: Hypofractionated Radiation by CyberKnife as a Mean of the Tumor Site's Radiation After Conventional Breast Radiation. [NA]

View source ↗

Summary

A completed clinical trial evaluating hypofractionated radiation delivered by CyberKnife as a boost after conventional breast irradiation in breast cancer patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Antoine Lacassagne | Conditions: Breast Cancer | NA | Status: COMPLETED